The first American investigation of Medicare coverage of biologic disease modifying drugs (DMARDs) found that in starting a single biologic DMARD, patients face more than $2,700 in copayments each year before receiving relief from catastrophic coverage.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1Hg6qmd
No comments:
Post a Comment